Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats

Diabetologia

Volumn 48, Issue 12, 2005, Pages 2675-2681

  Alves, M ^a   Calegari, V C ^a   Cunha, D A ^a   Saad, M J A ^a   Velloso, L A ^a   Rocha, E M ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Advanced glycated end products; Diabetes; Dry eye; Lacrimal gland; Nuclear factor kappa B

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA; DRY EYE; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LACRIMAL DUCT; LACRIMAL FLUID; LACRIMAL FLUID LEVEL; LACRIMAL GLAND; LACRIMATION; MALE; MEDICAL ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPECIES COEXISTENCE; STREPTOZOCIN DIABETES; TEAR FILM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CONJUNCTIVA; CORNEA; DIABETES MELLITUS, EXPERIMENTAL; DRY EYE SYNDROMES; GENE EXPRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; LACRIMAL APPARATUS; MALE; NF-KAPPA B; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; TEARS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28444438546     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-0010-9     Document Type: Article

References (38)

1. Ramos-Remus C, Suarez-Almazor M, Russell AS (1994) Low tear production in patients with diabetes mellitus is not due to Sjogren's syndrome. Clin Exp Rheumatol 12:375-380
2. Seifart U, Strempel I (1994) The dry eye and diabetes mellitus. Ophthalmologe 91:235-239
3. Goebbels M (2000) Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol 84:19-21
4. Dogru M, Katakami C, Inoue M (2001) Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 108:586-592
5. Hyndiuk RA, Kazarian EL, Schultz RO, Seideman S (1977) Neurotrophic corneal ulcers in diabetes mellitus. Arch Ophthalmol 95:2193-2196
6. Ishida N, Rao GN, del Cerro M, Aquavella JV (1984) Corneal nerve alterations in diabetes mellitus. Arch Ophthalmol 102:1380-1384
7. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK (1992) Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol 110:537-540
8. McNamara NA, Brand RJ, Polse KA, Bourne WM (1998) Corneal function during normal and high serum glucose levels in diabetes. Invest Ophthalmol Vis Sci 39:3-17
9. Rocha EM, de MLMH, Carvalho CR et al (2000) Characterization of the insulin-signaling pathway in lacrimal and salivary glands of rats. Curr Eye Res 21:833-842
10. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44:129-146
11. Bierhaus A, Schiekofer S, Schwaninger M et al (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792-2808
12. Portero-Otin M, Pamplona R, Bellmunt MJ et al (2002) Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes 51:1535-1542
13. Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151
14. Zoukhri D, Hodges RR, Byon D, Kublin CL (2002) Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci 43:1429-1436
15. Rocha EM, Wickham LA, Huang Z et al (1998) Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjogren's syndrome. Adv Exp Med Biol 438:485-491
16. Solomon A, Dursun D, Liu Z et al (2001) Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 42:2283-2292
17. Stitt AW, Moore JE, Sharkey JA et al (1998) Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Vis Sci 39:2517-2523
18. Kalfa TA, Gerritsen ME, Carlson EC et al (1995) Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci 36:2358-2367
19. Moore TC, Moore JE, Kaji Y et al (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 44:4457-4464
20. Howes KA, Liu Y, Dunaief JL et al (2004) Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci 45:3713-3720
21. Hammes HP, Hoerauf H, Alt A et al (1999) N(epsilon) (carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci 40:1855-1859
22. Ahmed N, Thornalley PJ, Dawczynski J et al (2003) Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest Ophthalmol Vis Sci 44:5287-5292
23. Das BK, Sun TX, Akhtar NJ et al (1998) Fluorescence and immunochemical studies of advanced glycation-related lens pigments. Invest Ophthalmol Vis Sci 39:2058-2066
24. Saxena P, Saxena AK, Cui XL et al (2000) Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest Ophthalmol Vis Sci 41:1473-1481
25. Rakieten N, Rakieten ML, Nadkarni MV (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91-98
26. Junod A, Lambert AE, Orci L et al (1967) Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 126:201-205
27. Herzog V, Sies H, Miller F (1976) Exocytosis in secretory cells of rat lacrimal gland. Peroxidase release from lobules and isolated cells upon cholinergic stimulation. J Cell Biol 70:692-706
28. Stoppiglia LF, Nogueira TA, Leite AR et al (2002) Protective effect of D-glucose, L-leucine and fetal calf serum against oxidative stress in neonatal pancreatic islets. Biochim Biophys Acta 1588:113-118
29. Vaisse C, Halaas JL, Horvath CM et al (1996) Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95-97
30. Koito W, Araki T, Horiuchi S, Nagai R (2004) Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. J Biochem (Tokyo) 136:831-837
31. Kaji Y, Usui T, Oshika T et al (2000) Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 41:362-368
32. Bromberg BB, Welch MH (1985) Lacrimal protein secretion: comparison of young and old rats. Exp Eye Res 40:313-320
33. Adeghate E, Ponery A, Hameed R (2005) Notes on the effect of diabetes mellitus on the morphology and function of the rat lacrimal gland. The Ocular Surface 3: S42 [Abstract]
34. Paliwal A, Srikantan AQ, Stephano PK (2005) Androgen, estrogen and thyroid hormones repress tear peroxidase gene in lacrimal gland of hamster. The Ocular Surface 3:S102 [Abstract]
35. Hofmann MA, Drury S, Fu C et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901
36. Degenhardt TP, Alderson NL, Arrington DD et al (2002) Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61:939-950
37. Kern TS, Tang J, Mizutani M et al (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972-3978
38. Peponis V, Papathanasiou M, Kapranou A et al (2002) Protective role of oral antioxidant supplementation in ocular surface of diabetic patients. Br J Ophthalmol 86:1369-1373